Ask me later
Ask me later
How likely are you to recommend Redeye to a friend or colleague?
1
2
3
4
5
6
7
8
9
10
Not likely
Very likely
Not likely
1
2
3
4
5
6
7
8
9
10
Very likely
Message received
Thanks again for rating us!
May 11 2021
07:00-08:30
Strategy Update: AlzeCure Pharma
About event
Schedule
Event Videos
Updated
18:10
Participating
ALZECURE UPDATE ON PROGRESS IN THEIR PAINLESS PLATFORM
Welcome to a Redeye event where AlzeCure will give a presentation on its project platform Painless and the progress made, with recent positive clinical results from the ACD440 phase Ib trial for neuropathic pain and advancements made in the TrkA-NAM pain project, projects that complement AlzeCure’s broad Alzheimer’s portfolio.
Presenting will be Martin Jönsson, CEO, Märta Segerdahl, CMO, Pontus Forsell, Head of Discovery & Research and Johan Sandin, CSO. The event will include a Q&A session and discussion led by Anders Hedlund, analyst at Redeye.
This event will be presented in English
Location
Live stream at Redeye.se/events